CANTON - TrialAssure, a leading software-as-a-service provider advancing clinical trial disclosure, data sharing, and transparency, announced today that it is collaborating with MMS, a global clinical research organization, on a new artificial intelligence initiative aimed at developing generative text specifically for medical writing in the field of drug development. The primary focus of this collaboration
CANTON – MMS Holdings has restructured its consulting services with the launch of a Project Advisory Services Unit to meet the needs for senior-level guidance for small to mid-sized organizations for specialized consulting, and advisory services. MMS Project Advisory Services will be led by Jessica Reed, PhD, and includes a growing team of more than 50 expert advisors in regulatory, clinical, nonclinical, compliance and CMC. In this role, Jessica will continue to
CANTON – MMS Holdings – a data-focused CRO – announced this week the addition of Kevin Chartier, Ph.D., as Principal Advisor of Biostatistics and Submissions Planning. Chartier will work with the biostatistics team across MMS global operations to support Sponsors with complex studies and submissions. Bringing more than 25 years of statistics experience, Chartier has held positions at Astellas Pharma, Novartis, Wyeth, Pfizer, and United BioSource Corporation across
CANTON TWP.–MMS Holdings, a contract research organization for the pharmaceutical industry, has joined the Decentralized Trials and Research Alliance, an organization launched in December to unite healthcare companies, regulators, patient groups and research organizations to make clinical trial participation widely accessible by advancing policies, research practices, and new technologies in decentralized clinical research. “As a
CANTON – MMS, a contract biotech research organization, is offering a $1 million award toward the development of a vaccine for COVID-19, also known as the coronavirus. The award is being offered as data and related services to qualified pharmaceutical and clinical research companies supporting the commercial development of a vaccine for approval in the
